Publications by authors named "O B Adeoye"

Cerebral malaria (CM) is a fatal complication of Plasmodium falciparum infection. The biological and physiological links between CM, inflammation, and inflammasome, point to the complexity of its pathology. Resistance to available and affordable drugs, worsening economic crisis, and urgent need for integration of orthodox with traditional/alternative medicine, actualized the search for sustainable pharmacotherapy.

View Article and Find Full Text PDF

Although heparin-induced thrombocytopenia (HIT) presents management challenges for any population, it adds complexity to the management of certain patient populations, including those undergoing cardiac surgery and those with refractory HIT and/or acute bleeding. For each of these scenarios, we review alternative management strategies when standard therapies-heparin cessation and the initiation of a nonheparin anticoagulant-are either insufficient or not practicable. In patients with HIT undergoing cardiac surgery, we review the clinical experience for heparin reexposure using therapeutic plasma exchange (TPE) or antiplatelet therapy.

View Article and Find Full Text PDF

Background: Sickle cell disease (SCD) is of serious public health concern. Paucity of literature exists on qualitative experiences of people with SCD, despite substantial research on the clinical signs and management of the disease. This study examined how SCD affects a range of undergraduate students' experiences, their academic achievements, relationships, mental health and healthcare utilization.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical trials indicate that using a mobile stroke unit (MSU) for prehospital management can lead to better outcomes for acute ischemic stroke patients who may need thrombolysis, but real-world data is limited.
  • This study aimed to compare the effects of prehospital MSU management versus standard emergency services (EMS) on patient disability levels at the time of hospital discharge.
  • The analysis included over 19,000 patients treated across multiple hospitals, revealing that those managed in an MSU had improved functional outcomes compared to those receiving standard EMS care.*
View Article and Find Full Text PDF
Article Synopsis
  • A survey was conducted among NIH StrokeNet hospitals to assess how often practitioners administer intravenous thrombolysis to ischemic stroke patients who recently used Direct Oral Anticoagulants (DOACs).
  • 78.3% of responders would not give thrombolysis to eligible patients within 12-24 hours after last DOAC use, and 54.2% would not do so within 24-48 hours.
  • The study suggests that if future research shows low rates of symptomatic intracranial hemorrhage, many practitioners, especially vascular neurologists, would reconsider their current practices regarding thrombolysis in such patients.
View Article and Find Full Text PDF